Home › NDC Lookup › RxCUI directory › RxCUI 1366196

Clobazam 2.5 MG/ML Oral Suspension [Onfi] — RxCUI 1366196

RxNorm drug concept · Semantic branded drug
RxCUI 1366196 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1366196
Official nameClobazam 2.5 MG/ML Oral Suspension [Onfi]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asOnfi 2.5 MG/ML Oral Suspension; Onfi 2.5 MG in 1 mL Oral Suspension; Onfi 2.5 MG per 1 ML Oral Suspension
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)18,921 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clobazam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clobazam is prescribed as an add-on seizure medication for people with Lennox-Gastaut Syndrome (LGS), a severe form of epilepsy. It works alongside other seizure medicines — it's n...
  • It's best to avoid alcohol completely while you're taking clobazam. Alcohol is itself a sedative, and when combined with clobazam it can boost clobazam levels in your blood by abou...
  • Is it okay to have a drink of alcohol while I'm on clobazam?
  • The most common things people notice are drowsiness, low energy, drooling, constipation, and sometimes fever or irritability. Drowsiness is most common early on and often improves...
📖 Read our full Clobazam guide →

🕸️ Concept Web — How Clobazam 2.5 MG/ML Oral Suspension [Onfi] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clobazam 2.5 MG/ML Oral Suspension [Onfi] RxCUI 1366196

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clobazam 21241
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Onfi 1191051
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clobazam Oral Suspension 1366191
    • Clobazam Oral Liquid Product 1366190
    • Clobazam Oral Product 1163749
    • Clobazam Oral Suspension [Onfi] 1366194
    • Onfi Oral Liquid Product 1366195
    • Onfi Oral Product 1191054
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clobazam 2.5 MG/ML Oral Suspension SCD · 1366192
  • Clobazam 2.5 MG/ML SCDC · 1366189
  • Clobazam Oral Suspension SCDF · 1366191
  • Clobazam Oral Liquid Product SCDG · 1366190
  • Clobazam Oral Product SCDG · 1163749

Brand-Name Concepts

  • Clobazam 2.5 MG/ML [Onfi] SBDC · 1366193
  • Clobazam Oral Suspension [Onfi] SBDF · 1366194
  • Onfi Oral Liquid Product SBDG · 1366195
  • Onfi Oral Product SBDG · 1191054
  • Onfi BN · 1191051

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 1366196 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
67386-0313-21 1 BOTTLE in 1 CARTON (67386-313-21) / 120 mL in 1 BOTTLE Onfi Lundbeck Pharmaceuticals LLC 2012-12-14
67386-0314-01 1 BOTTLE in 1 CARTON (67386-314-01) / 100 TABLET in 1 BOTTL... Onfi Lundbeck Pharmaceuticals LLC 2013-12-10
67386-0315-01 1 BOTTLE in 1 CARTON (67386-315-01) / 100 TABLET in 1 BOTTL... Onfi Lundbeck Pharmaceuticals LLC 2013-12-10
Observed labelers: Lundbeck Pharmaceuticals LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.